A Study of Using fMRI to Diagnose the Chronic Pain of Central Sensitization Syndrome

Overview

About this study

The purpose of this study is to develop fMRI as an objective tool for the diagnosis of the chronic pain of central sensitization syndrome.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Adult, age 18-88 years
  • Has fibromyalgia 
  • Must be able to come for the 3 month follow-up appointment

Exclusion Criteria:

  • Takes opioid and benzodiazepine medication
  • Left handed
  • Pregnancy
  • Preexisting central nervous system pathology like MS, brain tumor, brain surgery, or stroke
  • Contraindications to MRI like pacemaker, spinal cord stimulator, metal-implants, and claustrophobia

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Prasanna Vibhute, M.D.

Open for enrollment

Contact information:

Erica Cook

127or7833543

Cook.Erica@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20462691

Mayo Clinic Footer